Stocks to Keep Your Eyes on: SeaWorld Entertainment Inc (NYSE:SEAS), Vonage Holdings Corp. (NYSE:VG), Cempra Inc (NASDAQ:CEMP)

On Monday, Shares of SeaWorld Entertainment Inc (NYSE:SEAS), added 4.90% and closed at $14.14 in the last trading session. The last trading range of the stock ranges between $13.51 and $14.21. Shareholder Rights Law Firm Johnson & Weaver, LLP, is investigating potential claims against Cognizant Technology Solutions Corporation, BofI Holding, Inc, Seres Therapeutics, Inc., SeaWorld Entertainment, Inc., and ProNAi Therapeutics, Inc., as detailed below.

Johnson & Weaver, LLP, is investigating potential violations of the federal securities laws by Cognizant Technology Solutions Corporation (CTSH) and certain of its officers. On September 30, 2016, Cognizant made known that it was conducting an internal investigation into whether certain payments in India violated the U.S. Foreign Corrupt Practices Act. Cognizant also declared that its president had resigned. On this news, shares of Cognizant closed down sharply on September 30, 2016.

Vonage Holdings Corp. (NYSE:VG), jumped 0.45% and closed at $6.64 in the last trading session. The last trading range of the stock ranges between $6.51 and $6.70. The company’s Market capitalization is $1.46 Billion with the total Outstanding Shares of 216.43 million. Vonage Holdings Corp. provides communications services connecting people through cloud-connected devices worldwide. It offers various business services, counting basic dial tone, call queue, conferencing, call groups, mobile functionality, CRM integration, and detailed analytics, in addition to Vonage Essential services. The company also provides home telephone replacement services through various service plans with basic features, such as voicemail, call waiting, call forwarding, simulring, visual voicemail, and extensions, in addition to area code selection, virtual phone number, and Web-facilitated voicemail. Its primary home telephone offering is Vonage World that offers unlimited domestic calling; calling to landline phones in about 60 countries; and calling to mobile phones in various countries. mobile services, counting Vonage Mobile, a mobile application that provides free calling and messaging between users who have the application, in addition to international calling to other phone; and Vonage-facilitated devices, which allow customers to use the Internet connection for their computer and telephones at the same time. Further, it offers high-speed broadband Internet service that allows calls over the Internet either from a telephone through a Vonage-facilitated device, or through soft phone software, or mobile client applications.

Cempra Inc (NASDAQ:CEMP), lost -4.50% and closed at $23.11 in the last trading session. The last trading range of the stock ranges between $22.42 and $24.14. During the 52-week trading session the minimum price at which share price traded, registered at $14.03 and reached to max level of $34.79. Cempra, Inc. (CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, recently declared interim results showing anti-NASH effects in the first six nonalcoholic steatohepatitis (NASH) patients dosed with solithromycin in a Phase 2 study.

Contrast with baseline values, after 90 days of solithromycin treatment, all six NASH patients had a reduction in their nonalcoholic fatty liver disease (NAFLD) activity score (NAS) (mean reduction, 1.3) and their alanine aminotransferase (ALT) (mean reduction, 17.8 U/L). Five of six patients had a reduction in their aspartate aminotransferase (AST), and the sixth patient had an AST that was unchanged and normal (mean reduction for the six patients, 10.1 U/L).

There were also mean reductions in ballooning hepatocyte degeneration and inflammation, both of which are histological signs of NASH.

Solithromycin has been well tolerated in this study.

According to the National Institutes of Health, up to 16 million Americans, or two to five percent of the U.S. population, has NASH.


Leave a Reply

Your email address will not be published. Required fields are marked *